Literature DB >> 2174715

Org2766 improves performance of rats with unilateral lesions in the fimbria fornix in a spatial learning task.

B Spruijt1, N Pitsikas, S Algeri, W H Gispen.   

Abstract

ACTH and related peptides are known for their effects on behavior and for their efficacy on peripheral nerve regeneration. More recently, evidence demonstrating neurotrophic effects of Org2766 on recovery after damage of the central nervous system has become available. Aging studies indicated that particularly the hippocampus appears susceptible to peptide treatment. Therefore, in this study the neurotrophic influence of Org2766 on recovery of hippocampal functioning was studied after transection of the fimbria fornix connection. Analogous to results obtained with recovery of sensorimotor function following peripheral nerve damage a chronic treatment with Org2766 facilitates recovery of the impaired function, i.e. spatial learning in a Morris maze. However, the lesion-induced impairment of avoidance behavior was not influenced by the peptide treatment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2174715     DOI: 10.1016/0006-8993(90)91137-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Nasal administration of an ACTH(4-9) peptide analogue with dimethyl-beta-cyclodextrin as an absorption enhancer: pharmacokinetics and dynamics.

Authors:  N G Schipper; J C Verhoef; L M De Lannoy; S G Romeijn; J H Brakkee; V M Wiegant; W H Gispen; F W Merkus
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

2.  1H-NMR imaging of fimbria fornix lesions in the rat brain.

Authors:  R M Dijkhuizen; H J Muller; K S Tamminga; H A van Doremalen; B M Spruijt; K Nicolay
Journal:  Brain Topogr       Date:  1992       Impact factor: 3.020

3.  A dose-response analysis of the beneficial effects of the ACTH-(4-9) analogue, Org 2766, on behavioural recovery following unilateral labyrinthectomy in guinea-pig.

Authors:  D P Gilchrist; C L Darlington; P F Smith
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.